Advances in Image-Guided Diagnosis and Treatment of Abdominal Diseases

A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Medical Imaging and Theranostics".

Deadline for manuscript submissions: closed (30 September 2022) | Viewed by 20982

Special Issue Editors


E-Mail Website
Guest Editor
1. Department of Radiology, ASST Papa Giovanni XXIII Hospital, 24127 Bergamo, Italy
2. School of Medicine and Surgery, University of Milano-Bicocca, 24127 Bergamo, Italy
Interests: liver vascular malformations and portal vein thrombosis; vascular and biliary complications of liver transplant; liver cancer; pediatric interventional radiology; contrast-enhanced and color doppler ultrasound; multiparametric MRI; CT-angiography
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Vascular and Interventional Radiology, Cardarelli Hospital, 80131 Naples, Italy
Interests: embolization; emergency; oncology; biliary; liver; conebeam-CT; CT; DSA; US

Special Issue Information

Dear Colleagues,

This topic will report on standards and cutting-edge techniques for the diagnosis of several abdominal diseases in children and adults. Emphasis will be given to technologic improvements that allow non-invasive tissue characterization with pathological correlation: the emerging role of radiomics, artificial intelligence (AI), multiparametric and functional imaging will be stressed both in radiology and nuclear medicine.

Mini-invasive image-guided strategies for tissue sampling, cytology and micro-histologic assessment in infectious and onco-hematologic diseases will be discussed.

Differential diagnoses and pitfalls of imaging will be presented to help scholars to be aware of the possible diagnostic issues.

The role of interventional radiological treatments will be presented both in benign and malignant diseases, when appropriate. Nowadays, mini-invasive image-guided therapies provide new approaches to benign pathologies that have traditionally been managed with surgery (prostatic hypertrophy; uterine fibroids; biliary stones). Moreover, loco-regional therapies are increasingly being combined with oncologic treatments, and indications to radiotherapy, especially with its selective applications (SIRT; SBRT; SABR), are expanding.

Finally, imaging assessment after treatment and during follow up, which requires knowledge of the mechanisms of action of therapies and their possible complications, will be stressed.

We invite authors to form different radiology and nuclear medicine subspecialities to provide their knowledge, contributing with both original research and review articles. Particularly, contributions from authors of referral centers for advanced therapies will be welcomed.

Dr. Paolo Marra
Dr. Francesco Giurazza
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Published Papers (8 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Editorial

Jump to: Research, Review, Other

3 pages, 183 KiB  
Editorial
Special Issue on “Advances in Image-Guided Diagnosis and Treatment of Abdominal Diseases”
by Paolo Marra and Francesco Giurazza
Diagnostics 2023, 13(2), 169; https://0-doi-org.brum.beds.ac.uk/10.3390/diagnostics13020169 - 04 Jan 2023
Cited by 1 | Viewed by 976
Abstract
This Special Issue is a collection of five scientific papers and five reviews concerning current topics in abdominal imaging with attention on the diagnosis and interventional management of specific diseases [...] Full article

Research

Jump to: Editorial, Review, Other

10 pages, 745 KiB  
Article
Individualized Contrast Media Application Based on Body Weight and Contrast Enhancement in Computed Tomography of Livers without Steatosis
by Daan J. de Jong, Véronique V. van Cooten, Wouter B. Veldhuis, Pim A. de Jong and Madeleine Kok
Diagnostics 2022, 12(7), 1551; https://0-doi-org.brum.beds.ac.uk/10.3390/diagnostics12071551 - 25 Jun 2022
Cited by 3 | Viewed by 1887
Abstract
This study analyzes the homogeneity in liver attenuation of a body-weight-based protocol compared to a semi-fixed protocol. Patients undergoing abdominal multiphase computed tomography received 0.500 g of iodine (gI) per kilogram of body weight. Liver attenuation and enhancement were determined using regions of [...] Read more.
This study analyzes the homogeneity in liver attenuation of a body-weight-based protocol compared to a semi-fixed protocol. Patients undergoing abdominal multiphase computed tomography received 0.500 g of iodine (gI) per kilogram of body weight. Liver attenuation and enhancement were determined using regions of interest on scans in the pre-contrast and portal venous phases. The outcomes were analyzed for interpatient uniformity in weight groups. The subjective image quality was scored using a four-point Likert scale (excellent, good, moderate, and nondiagnostic). A total of 80 patients were included (56.3% male, 64 years, 78.0 kg) and were compared to 80 propensity-score-matched patients (62.5% male, 63 years, 81.7 kg). The liver attenuation values for different weight groups of the TBW-based protocol were not significantly different (p = 0.331): 109.1 ± 13.8 HU (≤70 kg), 104.6 ± 9.70 HU (70–90 kg), and 105.1 ± 11.6 HU (≥90 kg). For the semi-fixed protocol, there was a significant difference between the weight groups (p < 0.001): 121.1 ± 12.1 HU (≤70 kg), 108.9 ± 11.0 HU (70–90 kg), and 105.0 ± 9.8 HU (≥90 kg). For the TBW-based protocol, the enhancement was not significantly different between the weight groups (p = 0.064): 46.2 ± 15.1 HU (≤70 kg), 59.3 ± 6.8 HU (70–90 kg), and 52.1 ± 11.7 HU (≥90 kg). Additionally, for the semi-fixed protocol, the enhancement was not significantly different between the weight groups (p = 0.069): 59.4 ± 11.0 HU (≤70 kg), 53.0 ± 10.3 HU (70–90 kg), and 52.4 ± 7.5 HU (≥90 kg). The mean administered amount of iodine per kilogram was less for the TBW-based protocol compared to the semi-fixed protocol: 0.499 ± 0.012 and 0.528 ± 0.079, respectively (p = 0.002). Of the TBW-based protocol, 17.5% of the scans scored excellent enhancement quality, 76.3% good, and 6.3% moderate. Of the semi-fixed protocol, 70.0% scored excellent quality, 21.3% scored good, and 8.8% scored moderate. In conclusion, the TBW-based protocol increased the interpatient uniformity of liver attenuation but not the enhancement in the portal venous phase compared to the semi-fixed protocol, using an overall lower amount of contrast media and maintaining good subjective image quality. Full article
Show Figures

Figure 1

11 pages, 1226 KiB  
Article
Association between Preoperative Retrograde Hepatic Vein Flow and Acute Kidney Injury after Cardiac Surgery
by Csaba Eke, András Szabó, Ádám Nagy, Boglár Párkányi, Miklós D. Kertai, Levente Fazekas, Attila Kovács, Bálint Lakatos, István Hartyánszky, János Gál, Béla Merkely and Andrea Székely
Diagnostics 2022, 12(3), 699; https://0-doi-org.brum.beds.ac.uk/10.3390/diagnostics12030699 - 12 Mar 2022
Cited by 5 | Viewed by 1969
Abstract
Key questions: Is there a predictive value of hepatic venous flow patterns for postoperative acute kidney injury (AKI) after cardiac surgery? Key findings: In patients who underwent cardiac surgery, retrograde hepatic venous waves (A, V) and their respective ratio to anterograde waves showed [...] Read more.
Key questions: Is there a predictive value of hepatic venous flow patterns for postoperative acute kidney injury (AKI) after cardiac surgery? Key findings: In patients who underwent cardiac surgery, retrograde hepatic venous waves (A, V) and their respective ratio to anterograde waves showed a strong association with postoperative AKI, defined as the percentage change of the highest postoperative serum creatinine from the baseline preoperative concentration (%ΔCr). The velocity time integral (VTI) of the retrograde A wave and the ratio of the retrograde and anterograde waves’ VTI were independently associated with AKI after adjustment for disease severity. Take-home message: A higher ratio of retrograde/antegrade waves in hepatic venous retrograde waves, which are related to hepatic stasis, may predict AKI after cardiac surgery. Introduction: Hepatic venous flow patterns reflect pressure changes in the right ventricle and are also markers of systemic venous congestion. Pulsatility of the inferior caval vein was used to predict the risk of acute kidney injury (AKI) after cardiac surgery. Aims: Our objective was to evaluate the association between preoperative hepatic venous flow patterns and the risk of AKI in patients after cardiac surgery. Methods: This prospective, observational study included 98 patients without preexisting liver disease who underwent cardiac surgery between 1 January 2018, and 31 March 2020, at a tertiary heart center. In addition to a routine echocardiographic examination, we recorded the maximal velocity and velocity time integral (VTI) of the standard four waves in the common hepatic vein with Doppler ultrasound. Our primary outcome measure was postoperative AKI, defined as the percentage change of the highest postoperative serum creatinine from the baseline preoperative concentration (%ΔCr). The secondary outcome was AKI, defined by KDIGO (Kidney Disease Improving Global Outcomes) criteria. Results: The median age of the patients was 69.8 years (interquartile range [IQR 25–75] 13 years). Seventeen patients (17.3%) developed postoperative AKI based on the KDIGO. The VTI of the retrograde A waves in the hepatic veins showed a strong correlation (B: 0.714; p = 0.0001) with an increase in creatinine levels after cardiac surgery. The velocity time integral (VTI) of the A wave (B = 0.038, 95% CI = 0.025–0.051, p < 0.001) and the ratio of VTI of the retrograde and anterograde waves (B = 0.233, 95% CI = 0.112–0.356, p < 0.001) were independently associated with an increase in creatinine levels. Conclusions: The severity of hepatic venous regurgitation can be a sign of venous congestion and seems to be related to the development of AKI. Full article
Show Figures

Graphical abstract

9 pages, 4358 KiB  
Article
EVAR Follow-Up with Ultrasound Superb Microvascular Imaging (SMI) Compared to CEUS and CT Angiography for Detection of Type II Endoleak
by Marco Curti, Filippo Piacentino, Federico Fontana, Christian Ossola, Andrea Coppola, Paolo Marra, Antonio Basile, Anna Maria Ierardi, Gianpaolo Carrafiello, Giulio Carcano, Matteo Tozzi, Gabriele Piffaretti and Massimo Venturini
Diagnostics 2022, 12(2), 526; https://0-doi-org.brum.beds.ac.uk/10.3390/diagnostics12020526 - 18 Feb 2022
Cited by 5 | Viewed by 2204
Abstract
The aim of this study was to evaluate the usefulness of superb microvascular imaging (SMI) versus contrast-enhanced ultrasound (CEUS) and compared to computed tomography angiography (CTA) as a reference standard, for detection of type II endoleak during follow-up of endovascular abdominal aortic aneurysm [...] Read more.
The aim of this study was to evaluate the usefulness of superb microvascular imaging (SMI) versus contrast-enhanced ultrasound (CEUS) and compared to computed tomography angiography (CTA) as a reference standard, for detection of type II endoleak during follow-up of endovascular abdominal aortic aneurysm repair (EVAR). Between April 2017 and September 2020, 122 patients underwent post-EVAR follow-up with CTA at 3 months and with ultrasound SMI and CEUS at 4 months from the EVAR procedure. Aneurysmal sac diameter and graft patency were evaluated; endoleaks were assessed and classified. Sensitivity, specificity, positive and negative predictive values, and diagnostic accuracy were calculated both for SMI and CEUS and compared to CTA. Furthermore, the percentage of agreement and Cohen’s Kappa coefficient were calculated. CTA revealed 54 type II endoleaks. Ultrasound SMI and CEUS presented the same sensitivity (91.5%), specificity (100%), positive (100%), and negative (92.8%) predictive and accuracy (95.9%) value for detecting type II endoleak. The same percentage of agreement of 94.9% was found between SMI/CEUS, and CTA with a Cohen’s Kappa coefficient of 0.89. The diagnostic accuracy of SMI is comparable with CEUS in the identification of type II endoleaks after EVAR. Since SMI is less invasive, less expensive, and less time-consuming, this method may be considered to be a potential tool for monitoring patients after EVAR implantation. Full article
Show Figures

Figure 1

11 pages, 2439 KiB  
Article
Association of Hepatic Steatosis Index with Nonalcoholic Fatty Liver Disease Diagnosed by Non-Enhanced CT in a Screening Population
by Jieun Chung, Hee-Sun Park, Young-Jun Kim, Mi-Hye Yu, Sungeun Park and Sung-Il Jung
Diagnostics 2021, 11(12), 2168; https://0-doi-org.brum.beds.ac.uk/10.3390/diagnostics11122168 - 23 Nov 2021
Cited by 12 | Viewed by 2008
Abstract
The noninvasive diagnosis of hepatic steatosis is of increasing concern. This study investigated the association of hepatic steatosis determined by non-enhanced CT criteria with clinical parameters in a screening population. Asymptomatic patients who underwent abdominal CT at our healthcare center were retrospectively analyzed [...] Read more.
The noninvasive diagnosis of hepatic steatosis is of increasing concern. This study investigated the association of hepatic steatosis determined by non-enhanced CT criteria with clinical parameters in a screening population. Asymptomatic patients who underwent abdominal CT at our healthcare center were retrospectively analyzed (n = 339). Two radiologists measured the attenuation values of the liver parenchyma and spleen using non-enhanced CT images. CT criteria for hepatic steatosis were (a) absolute liver attenuation value <48 Hounsfield units (HU), (b) liver-to-spleen attenuation ratio <0.8, and (c) attenuation difference between the liver and spleen <−10. Body mass index (BMI) and hepatic steatosis index (HSI) were calculated, and laboratory findings were recorded. The association of hepatic steatosis with clinical parameters was assessed using univariate and logistic regression analyses. The presence of hepatic steatosis was significantly associated with the levels of serum fasting glucose and triglycerides, the alanine aminotransferase to aspartate aminotransferase (ALT/AST) ratio, BMI, and HSI values using any of the CT criteria. Logistic regression analysis revealed that the serum fasting glucose level and HSI were significantly associated with hepatic steatosis using criterion (a), while the ALT/AST ratio and HSI were associated with hepatic steatosis using criteria (b) and (c). The presence of hepatic steatosis on non-enhanced CT should be considered to indicate possible clinical profile abnormalities regarding metabolic syndrome. Full article
Show Figures

Figure 1

Review

Jump to: Editorial, Research, Other

27 pages, 2872 KiB  
Review
Intra-Abdominal Malignant Melanoma: Challenging Aspects of Epidemiology, Clinical and Paraclinical Diagnosis and Optimal Treatment—A Literature Review
by Sinziana Ionescu, Alin Codrut Nicolescu, Octavia-Luciana Madge, Laurentiu Simion, Marian Marincas and Mihai Ceausu
Diagnostics 2022, 12(9), 2054; https://0-doi-org.brum.beds.ac.uk/10.3390/diagnostics12092054 - 24 Aug 2022
Cited by 5 | Viewed by 3546
Abstract
According to European consensus-based interdisciplinary guidelines for melanoma, cutaneous melanoma (CM) is the most deadly form of dermatological malignancy, accounting for 90% of the deaths of skin cancer patients. In addition to cutaneous melanoma, mucosal melanoma occurs in four major anatomical sites, including [...] Read more.
According to European consensus-based interdisciplinary guidelines for melanoma, cutaneous melanoma (CM) is the most deadly form of dermatological malignancy, accounting for 90% of the deaths of skin cancer patients. In addition to cutaneous melanoma, mucosal melanoma occurs in four major anatomical sites, including the upper respiratory tract, the conjunctiva, the anorectal region, and the urogenital area. As this cancer type metastasizes, a classification used in the current medical literature is the distinction between secondary lesions and primary malignant melanoma of the abdominal cavity. Given that malignant melanoma is the most common cancer that spreads to the gastrointestinal tract, different imaging modalities compete to diagnose the phenomenon correctly and to measure its extension. Treatment is primarily surgery-based, supported by immunotherapy, and prolongs survival, even when performed at stage IV illness. In the end, special forms of malignant melanoma are discussed, such as melanoma of the genito-urinary tract and amelanotic/achromic melanoma. The importance of this present literature review relies on yielding and grouping consistent and relevant, updated information on the many aspects and challenges that a clinician might encounter during the diagnosis and treatment of a patient with intra-abdominal melanoma. Full article
Show Figures

Figure 1

13 pages, 1823 KiB  
Review
MRI Appearance of Focal Lesions in Liver Iron Overload
by Anna Pecorelli, Paola Franceschi, Lorenzo Braccischi, Federica Izzo, Matteo Renzulli and Rita Golfieri
Diagnostics 2022, 12(4), 891; https://0-doi-org.brum.beds.ac.uk/10.3390/diagnostics12040891 - 02 Apr 2022
Cited by 8 | Viewed by 6020
Abstract
Liver iron overload is defined as an accumulation of the chemical element Fe in the hepatic parenchyma that exceeds the normal storage. When iron accumulates, it can be toxic for the liver by producing inflammation and cell damage. This can potentially lead to [...] Read more.
Liver iron overload is defined as an accumulation of the chemical element Fe in the hepatic parenchyma that exceeds the normal storage. When iron accumulates, it can be toxic for the liver by producing inflammation and cell damage. This can potentially lead to cirrhosis and hepatocellular carcinoma, as well as to other liver lesions depending on the underlying condition associated to liver iron overload. The correct assessment of liver iron storage is pivotal to drive the best treatment and prevent complication. Nowadays, magnetic resonance imaging (MRI) is the best non-invasive modality to detect and quantify liver iron overload. However, due to its superparamagnetic properties, iron provides a natural source of contrast enhancement that can make challenging the differential diagnosis between different focal liver lesions (FLLs). To date, a fully comprehensive description of MRI features of liver lesions commonly found in iron-overloaded liver is lacking in the literature. Through an extensive review of the published literature, we aim to summarize the MRI signal intensity and enhancement pattern of the most common FLLs that can occur in liver iron overload. Full article
Show Figures

Figure 1

Other

4 pages, 4632 KiB  
Interesting Images
The Influence of Gd-EOB-DTPA on T2 Signal Behavior: An Example from Clinical Routine
by Paola Franceschi, Anna Pecorelli, Rita Golfieri and Matteo Renzulli
Diagnostics 2022, 12(8), 1811; https://0-doi-org.brum.beds.ac.uk/10.3390/diagnostics12081811 - 28 Jul 2022
Cited by 1 | Viewed by 1001
Abstract
In the literature, it has repeatedly been stated that the introduction of hepatospecific contrast agents in Magnetic Resonance Imaging prolongs the acquisition time due to the hepatobiliary phase, normally acquired 15–20 min after injection. Many efforts have been made to shorten the time-consuming [...] Read more.
In the literature, it has repeatedly been stated that the introduction of hepatospecific contrast agents in Magnetic Resonance Imaging prolongs the acquisition time due to the hepatobiliary phase, normally acquired 15–20 min after injection. Many efforts have been made to shorten the time-consuming protocols, and it was demonstrated that T2-Weighted Images (T2WI) and Diffusion-Weighted Images (DWI) acquired after Gd-EOB-DTPA show a comparable diagnostic capability to pre-contrast T2WI and DWI in the detection and characterization of hepatic tumors. Therefore, T2WI and DWI are usually acquired after the acquisition of vascular phases, in the dead time until the acquisition of the hepatobiliary phase. Unfortunately, contrast agents, especially Gd-EOB-DTPA, reduce the hydrogen nuclei’s relaxation time and modify signal intensity. We report a case in which, due to these limitations of the acquisition protocol, two hemangiomas showed an inhomogeneous, low signal on T2WI and DWI that was not visible in a follow-up scan a few days later. In conclusion, when liver lesions of unknown nature must be characterized, and there is a lack of previous radiological investigations, it could be useful to acquire pre-contrast T2WI and DWI to avoid diagnostic confusion, especially in non-tertiary centers. Full article
Show Figures

Figure 1

Back to TopTop